SHH and nonpapillary renal cell carcinoma: These data demonstrated that inhibiting SHH and WNT signaling produces synergistic effects on suppressing ccRCC cell proliferation, migration, and invasion, providing new rationales for novel combinational therapies using two signaling inhibitors.